Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.

BMJ (Clinical research ed.) - 24 Apr 2004

Yudkin Patricia, Munafò Marcus, Hey Kate, Roberts Sarah, Welch Sarah, Johnstone Elaine, Murphy Michael, Griffiths Siân, Walton Robert

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Cutaneous
Share to Genotype
Share to Nicotine
Share to Nicotinic Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Dopamine D2

Share to Smoking

Share to Smoking Cessation

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 15033882
DOI: 10.1136/bmj.38050.674826.AE
PMCID: PMC404497

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.PMID 15033882Read ↗

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.Semantic proximity Read ↗

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Semantic proximity Read ↗

The influence of genetics on nicotine dependence and the role of pharmacogenetics in treating the smoking habit.Semantic proximity Read ↗

Role of Genetic Susceptibility in Nicotine Addiction and Chronic Obstructive Pulmonary DiseaseSemantic proximity Read ↗

Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genesSemantic proximity Read ↗

Pharmacogenetic Optimization of Smoking Cessation Treatment.Semantic proximity Read ↗

Pharmacogenetics of smoking cessation therapySemantic proximity Read ↗

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.Semantic proximity Read ↗

Smoking cessation treatment: pharmacogenetic assessment.Semantic proximity Read ↗

Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolismSemantic proximity Read ↗

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Semantic proximity Read ↗

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.